Study reveals vaccine confidence declined considerably during COVID-19 pandemic

A new study suggests that, despite the success of the COVID-19 vaccination campaigns, vaccine confidence has declined significantly since the start of the pandemic.

Researchers from the University of Portsmouth carried out two anonymous surveys in the winters of 2019 and 2022 to investigate people's attitudes towards vaccinations and the factors that might underpin hesitancy and refusal.

By comparing the responses of more than 1,000 adults overall, they found the post-pandemic group was considerably less confident in vaccines than in the pre-pandemic one.

The paper, published in the medical journal Vaccine, revealed nearly one in four participants reported a fall in confidence since 2020, and this was observed regardless of participants’ age, gender, religious belief, education and ethnicity.

Dr Alessandro Siani, Associate Head (Students) of the School of Biological Sciences at the University of Portsmouth, said: "While vaccine hesitancy is not a new phenomenon, COVID-19 vaccines have been met with particular hostility despite the overwhelming scientific evidence of their safety and effectiveness.

"This isn’t just among conspiracy theorists though, but also those who don’t consider themselves ‘anti-vaxxers’ and had supported other vaccination campaigns in the past."

Participants were asked how much they agreed with statements including:

  • Vaccines are safe
  • I think vaccines should be a compulsory practice
  • I believe if I get vaccinated it would benefit the wellbeing of others
  • Vaccines are a necessity for our health and wellbeing

In both surveys participants who held religious beliefs were significantly more vaccine-hesitant than atheist and agnostic ones, and individuals from Black and Asian backgrounds were more hesitant than those belonging to White ethnicities. However, gender showed no association with vaccine confidence.

While these overall trends remained largely similar between the two surveys, some noteworthy changes were observed in the post-pandemic survey. For example, the analysis revealed that while in 2019 middle-aged participants were considerably more apprehensive about getting vaccinated than younger groups , this was not the case in the 2022 survey.

"This could be because COVID-19 infections notoriously lead to more severe outcomes in older patients," added Dr Siani.

"Young people who are infected rarely experience severe symptoms that lead to hospitalisation and death, so it’s possible that many have become complacent and don’t feel the need to get vaccinated. On the other hand, older people may have been more wary of the consequences of the infection, and more appreciative of the protection offered by the vaccine."

While providing precious insight into how the pandemic affected the public perspectives on vaccinations, the study is not without limitations. The original survey was designed as a standalone piece of research, so a different group of people had to be sampled in 2022. This resulted in a cross-sectional study as opposed to a longitudinal one.

Dr Siani explained: "We didn't expect a worldwide pandemic to break out only a few months after carrying out the 2019 survey. Because our findings don’t reflect the changing opinions of the same group of people over time, but rather a comparison of responses provided by two different cohorts, they should be interpreted with a grain of salt.

"However, the study is consistent with other observations suggesting that vaccine confidence may be yet another victim of the COVID-19 pandemic."

Siani A, Tranter A.
Is vaccine confidence an unexpected victim of the COVID-19 pandemic?
Vaccine. 2022 Oct 31:S0264-410X(22)01337-8. doi: 10.1016/j.vaccine.2022.10.061

Most Popular Now

Pfizer receives positive FDA Advisory Committee vo…

Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted that avail...

Engineered bacteria find tumors, then alert the au…

Combining discoveries in cancer immunology with sophisticated genetic engineering, Columbia University researchers have created a sort of "bacterial suicide squad" that ...

First nasal monoclonal antibody treatment for COVI…

A pilot trial by investigators from Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, tested the nasal administration of the ...

US FDA Advisory Committee votes to support effecti…

GSK plc (LSE/NYSE: GSK) announced that the US Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted that the avail...

"Semantic similarity" leads to novel dru…

The words that researchers use to describe their results can be harnessed to discover potential new treatments for Parkinson's disease, according to a new study published...

Tumour cells' response to chemotherapy is driven b…

Cancer cells have an innate randomness in their ability to respond to chemotherapy, which is another tool in their arsenal of resisting treatment, new research led by the...

Pfizer invests $43 billion to battle cancer

Pfizer Inc. (NYSE: PFE) and Seagen Inc. (Nasdaq: SGEN) today announced that they have entered into a definitive merger agreement under which Pfizer will acquire Seagen, a...

Pfizer's ZAVZPRET™ (zavegepant) migraine nasal spr…

Pfizer Inc. (NYSE: PFE) today announced the U.S. Food and Drug Administration (FDA) has approved ZAVZPRET™ (zavegepant), the first and only calcitonin gene-related peptid...

Gene and cell therapies to combat pancreatic cance…

Pancreatic cancer is an incurable form of cancer, and gene therapies are currently in clinical testing to treat this deadly disease. A comprehensive review of the gene an...

Scientists reveal a potential new approach to trea…

Scientists at the National Institutes of Health and Massachusetts General Hospital in Boston have uncovered a potential new approach against liver cancer that could lead ...

Normalizing tumor blood vessels may improve immuno…

A type of immune therapy called chimeric antigen receptor (CAR)-T cell therapy has revolutionized the treatment of multiple types of blood cancers but has shown limited e...

Digital twin opens way to effective treatment of i…

Inflammatory diseases like rheumatoid arthritis have complex disease mechanisms that can differ from patient to patient with the same diagnosis. This means that currently...